WE ARE BRACKEN

Meet the team that lives life science to support your growth and success.

What is Bracken? Bracken is a tall fern that grows wild in the region of England where our co-founder, Colin Miller, was born and raised. Characterized by its large, highly divided leaves, bracken is a tenacious and agile plant that thrives on six continents across the globe. As a fully remote, global team serving clients around the world, we connect with a bracken's determination to grow and thrive wherever it may be. To us, bracken leaves also represent the coming together of multiple disciplines in perfect alignment to produce rapid growth - and that’s exactly how we serve our customers. By bringing together an accomplished team of diverse professionals to leverage our expertise in consulting, marketing, and data, we provide services that help businesses grow wider and faster. Meet our team below, or visit our careers page to learn more about joining Bracken.

  • Consulting
  • Regulatory
  • Marketing Services
  • Analytics
  • Operations
  • Business Development
  • Leadership
  • All
Gitte Andreasen

Senior Partner 

Areas of Expertise: go-to-market strategy, global product launches, opinion leader management

Marketing Services

Gitte_headshot

Gitte Andreasen

Senior Partner 

Areas of Expertise: go-to-market strategy, global product launches, opinion leader management

Now a fractional Chief Marketing Officer at Bracken, Gitte's 18 years in the medical imaging field includes previous senior marketing management positions at GE Healthcare (Diagnostic Ultrasound & Bone Densitometry/Body Composition), Toshiba/Vital Images (Advanced Visualization), ESAOTE (Diagnostic Ultrasound & MRI). Philips Healthcare (Mammography), and IBA (Proton Therapy). Gitte has managed multiple global go-to-market strategies/planning, global product launches, marketing operations, opinion leader management, marketing staff development and is a certified Six Sigma Green Belt marketing.

Andrew Beck, MBA, CNMT

Senior Partner

Areas of Expertise: Radiopharmaceuticals, radiopharmaceutical strategy, commercial due diligence, commercialization, supply chain

Consulting

Marketing Services

imageedit_1_8065908884

Andrew Beck, MBA, CNMT

Senior Partner

Areas of Expertise: Radiopharmaceuticals, radiopharmaceutical strategy, commercial due diligence, commercialization, supply chain

Andrew (Andy) is a radiopharmaceutical industry executive with more than 30 years of extensive due diligence, commercial strategy, and leadership experience spanning the continuum of both the clinical and commercial sides of the diagnostic and therapeutic radiopharmaceutical, and molecular imaging businesses.  

Leveraging industry-specific expertise, Andy applies lessons learned to advise clients engaged in conducting commercial due diligence. By applying a history-based approach to designing M&A strategy, Andy has assisted clients to proactively prepare for potential challenges, significantly minimize risk, and maximize return of investment. During his career, he has performed due diligence and created a variety of strategies including those for the development, launch and commercialization of multiple industry-leading SPECT, PET, Radiopharmaceutical Therapy and Theranostic products. 

The unique characteristics of radiopharmaceuticals and the complex risks associated with operating in the radiopharmaceutical business requires a multifaceted approach to conducting due diligence. Andy offers clients a breadth of commercial due diligence consulting services including market analysis, market validation, competitive analysis, partner and supplier due diligence, as well as the assessment of both the known and hidden risks associated with nuclear supply chain, delivery logistics, staffing, reimbursement, financial, quality, and the regulatory environment. 

From raw material sourcing to the patient bedside, Andrew excels at applying 30+ years of industry-specific lessons learned to conducting thorough commercial due diligence and providing clients with strategic solutions to successfully navigate the complexity of the radiopharmaceutical business.  

Deepak Behera, MD

Senior Partner

Areas of Expertise: Medical affairs, clinical development, radiopharmaceuticals

Position Title

Deepak_headshot

Deepak Behera, MD

Senior Partner

Areas of Expertise: Medical affairs, clinical development, radiopharmaceuticals

Deepak Behera is a highly accomplished physician-scientist and strategist with over two decades of leadership experience in the medical, academic, and pharmaceutical sectors. His proficiency in medical affairs, clinical development, and radiopharmaceuticals, has been pivotal to the successful launch and commercialization of two industry-leading products.

His early clinical experience grounded him in practical insights before transitioning to academic translational research at Stanford University. His work at Stanford led to birth of two startups, five early-phase trials, and the co-authorship of two patents, highlighting his innovative approach to nuclear medicine.

Deepak’s transition to the pharmaceutical industry was marked by his impactful roles as Senior Medical Director, Head of Medical Affairs, Strategic Medical Director, and Chief Medical Officer. These positions saw him navigate complex clinical development landscapes, Phase I-III study designs, FDA interactions, and oversee the successful launch of two commercial products. Having worked collaboratively with American, European and Asian companies, Deepak is culturally sensitive and adaptable in a global medical landscape.

As a scholar, Deepak has enriched the medical discourse with over 20 peer-reviewed articles and 15 impactful lectures and presentations. His dedication to the medical community extends beyond his professional roles, as demonstrated by his active involvement in organizations like Adaptive Research, EPPIC Global, IASNM, and MISI. As an industry pioneer, Deepak’s embodies the seamless blend of medical expertise, innovative research, commercial understanding and strategic leadership in medical affairs and radiopharmaceuticals.

Liz Bloss, DVM

Managing Partner

Head of Regulatory

Areas of Expertise: Early IND submission strategies, FDA communications & interactions, orphan drug submissions

Consulting

Regulatory

Leadership

m1-removebg-preview

Liz Bloss, DVM

Managing Partner

Head of Regulatory

Areas of Expertise: Early IND submission strategies, FDA communications & interactions, orphan drug submissions

Liz is the Managing Partner and Regulatory Affairs lead of The Bracken Group. Her vast expertise in early IND submission strategies through NDA preparations including the FDA NDA review has helped many companies with their development programs. With a particular expertise in FDA communications and meeting preparations Liz leads and/or prepares companies for FDA interactions, notably with milestone meetings as part of the preparations of early IND through late-stage NDA preparations including labelling negotiations. Liz is also adept at orphan drug submissions, handling US Agent support for global clients and regulatory intelligence questions to further assist in the overall development strategies.

Martin Collyer, MSc, FCCA

Senior Partner

Areas of Expertise: Patient engagement support, business development, finance direction

Consulting

Regulatory

Leadership

Martin_Collyer_headshot

Martin Collyer, MSc, FCCA

Senior Partner

Areas of Expertise: Patient engagement support, business development, finance direction

As a seasoned executive in healthcare operations, patient engagement and strategy, Martin has held various leadership roles, all of which included managing teams and driving growth across both clinical and commercial operations. His expertise also includes patient recruitment and retention, strategic planning, execution, process optimization, and product design and development.

Most recently, Martin was the Head of Strategy and Innovation for the commercial engagement services at IQVIA. In this role he led the design and development of digitized patient services, partnering with Apple and Samsung, and oversaw the integration of their digital patient platform. He also developed and implemented the business plan for IQVIA’s digital patient engagement solution, led product development, expanded business development opportunities, and engineered a digital patient recruitment solution. Before joining IQVIA Martin was a senior executive at PRA Health Sciences as the insourced manager at Bayer Healthcare, responsible for developing patient engagement and recruitment strategies, partnering with third-party vendors, and assessing and qualifying the vendor management process.

As the Vice President of Operations, Bioclinica (now Clario) Martin was responsible for patient recruitment and retention where he provided leadership to the patient recruitment division, restructured operations post-acquisition, launched a patient recruitment platform, and developed a siteless clinical trial solution in collaboration with major pharmaceutical companies. At Hitachi Data Systems Martin was Manager of Life Sciences, business development, responsible for accelerating growth of sales and revenues for healthcare and life sciences solutions.

In addition to his leadership roles in healthcare operations, Martin held various senior executive roles in finance, more notably, CFO of Axis Healthcare, (now Huntsworth Health) and global finance direction for Wolters Kluwer. His role included directing the post-acquisition integration and reorganization of the finance and accounting departments, managing the transitioning to new accounting software, implementing a new chart of accounts, and establishing month-end close process and reporting.

Martin holds a Master of Science (MSc) in professional accountancy from the University of London, School of Economics and is a fellow of the Association of Chartered Certified Accountants (ACCA) in the UK.

Ansley Coombes

Account Manager

Position Title

CoombesAnsley-final (1)

Ansley Coombes

Account Manager

Ansley graduated from Iowa State University with a degree in Communication Studies and completed her Master’s of Marketing at Edinburgh Napier University in Scotland. She’s spent the past few years working in Europe, gaining marketing experience across various industries including several years in an agency environment. In her free time, Ansley enjoys traveling to new places, relaxing at the beach, and hiking.

Lisa D. Cooper, PhD, RAC

Senior Partner

Areas of Expertise: Regulatory affairs leadership, pre- and post- approval of drug products, regulatory document writing

Consulting

Regulatory

CooperLisa-final (1)

Lisa D. Cooper, PhD, RAC

Senior Partner

Areas of Expertise: Regulatory affairs leadership, pre- and post- approval of drug products, regulatory document writing

Lisa is a strategic regulatory affairs leader with her extensive pre- and post-approval experience with drug and biologic products in the settings of oncology, pulmonary, auto immune, and infectious diseases. Adept at interpreting and applying regulations and guidelines to successfully drive programs through innovative pathways. Skilled writer, composing persuasive regulatory documents.

Dawn Flitcraft

Fractional COO

Senior Partner

Areas of Expertise: Life science organization leadership, due diligence, M&A integration

Position Title

Dawn Flitcraft headshot-final

Dawn Flitcraft

Fractional COO

Senior Partner

Areas of Expertise: Life science organization leadership, due diligence, M&A integration

Dawn is an experienced and results-driven Life Science & Healthcare executive with more than 25 years in building and leading life science organizations. After earning a BS in nuclear medicine and biology, she began her career in the clinical setting prior to transitioning to the clinical research industry. She also holds a certification in M&A integration. Now, she was most recently President, Ethical Review Division (WCG IRB) for WCG and a member of the Executive team that brought together more than 30+ acquisitions to provide service and technology solutions to more than 2.5 million patients across 10,000 research sites supporting 4000+ trials. During her tenure at WCG she was named “2020 Most Inspiring People in the Life Science Industry” by PharmaVoice magazine. Prior to WCG, Dawn was COO and General Manager - North America for Keosys Medical Imaging. She also spent more than 12 years in various senior roles at Bioclinica (now Clario), leading the Business Transformation activities post-merger.  

Dawn is currently President, FLS Advisory & Consulting and fractional Chief Operating Officer at Bracken. 

Jim Gilligan, MSIB, PhD

Managing Partner

Areas of Expertise: Biotech/biopharma leadership, drug development, strategic planning

Leadership

Consulting

m5-removebg-preview-1

Jim Gilligan, MSIB, PhD

Managing Partner

Areas of Expertise: Biotech/biopharma leadership, drug development, strategic planning

Jim has a deep history of drug development and strategic planning, pharmacology and toxicology, due diligence, peptide-based therapeutics, rDNA product development, musculoskeletal diseases, cardiovascular disease, and psychedelic assisted psychotherapy. Jim has co-founded and helped lead multiple biopharma and bio-tech companies, including Tarsa Therapeutics, Herborium Inc., and Unigene Labs, where he oversaw the entire spectrum of drug development activities, including pharmacology and preclinical activities, CMC, clinical Phase I-III, as well as US and international regulatory strategies. He has executed numerous feasibility and licensing deals within the pharmaceutical industry, working frequently with investment bankers, venture capitalists, and brokers.

Lori Hahn

Office Manager

Operations

Lori_Hahn_-removebg-preview

Lori Hahn

Office Manager

In addition to working for the Law School Admission Council, in financial services, and, most recently, in elementary education for 15 years, Lori has held several administrative support roles during her career. In her free time, Lori enjoys spending as much time as possible "down the shore" with her husband and four grown children, working on DIY projects, and shopping for bargains.

Amy Jarvis

Marketing & Contracts Manager

Position Title

Amy Jarvis Headshot - FINAL

Amy Jarvis

Marketing & Contracts Manager

Amy graduated with a Bachelor of Arts from Susquehanna University in 2021. During her time there, she became the Editor-in-Chief of The Susquehanna Review, studied a semester of Marketing and Communications at the University of Stirling in Scotland, and discovered her passion for mixing writing and science. Amy’s previous work experiences include copywriting, social media management, editing, and event planning—all of which required a balance of creativity and logistics. In her free time, Amy is either reading a good book, writing her own novel, or engaging in impassioned discussions about Star Wars with her family and friends.

Marilyn Julien

Senior Partner

Areas of Expertise: Regulatory CMC development strategy, authoring INDs/IMPDs/CTAs, pre- and post- approval drug lifecycle management

Consulting

Regulatory

marilyn-removebg-preview

Marilyn Julien

Senior Partner

Areas of Expertise: Regulatory CMC development strategy, authoring INDs/IMPDs/CTAs, pre- and post- approval drug lifecycle management

Marilyn is a Senior Regulatory Consultant experienced in CMC development strategy and authoring of INDs, IMPDs, and CTAs for small and large molecule products. She recently served as Director Regulatory Affairs CMC-Biologics Early Development at BeiGene. She has vast expertise in both pre- and post-approval drug lifecycle management, including comparability protocols (commercial products)/comparability amendments (development products) and FDA formal meetings/EMA scientific advice meetings.

Jonathan Larkin, PhD

Senior Partner

Areas of Expertise: Research and development leadership, osteoarthritis therapeutic development, progressing molecules to candidate selection milestones

Position Title

LarkinJon-final (1)

Jonathan Larkin, PhD

Senior Partner

Areas of Expertise: Research and development leadership, osteoarthritis therapeutic development, progressing molecules to candidate selection milestones

Jon is an entrepreneurial-minded scientist with over 20 years of research and development experience in the pharma and biotech industry (spanning GSK, Eli Lilly and SynOA Therapeutics). While at GSK he was focused on osteoarthritis therapeutic development through leading and shaping corporate strategy and employing both biologics and small molecule-based approaches to discover and progress clinical candidates. At GSK, Jon’s lab discovered and progressed two molecules to the candidate selection milestone. Thereafter, he led the clinical development effort as Early Development Leader providing experience in drafting protocols and informed consents, investigator brochures as well as regulatory IND submissions and application of Good Clinical Practice guidelines. Jon received his PhD in Pathology and Cell Biology from Thomas Jefferson University where he studied hepatitis B virus immunopathology and the effects of antiviral drug treatment and alcohol consumption on viral replication and gene expression in a novel HBV SCID mouse model he developed.

Annie Liljegren

Creative Director

Marketing Services

Annie_Lilligren_Headshot-removebg-preview

Annie Liljegren

Creative Director

Annie's approach to content direction, development, and strategy is informed by her origins as a Salesforce admin coupled with an academic background. A firm believer that quality content begins with quality research, Annie spent several years teaching college composition, rhetoric, and speech to STEM/life science majors. Areas of special interest include "dialogue-centric" collateral presenting information via conversation: podcasts, success stories, or a well-crafted print interview.

Dr. Graham G. Lumsden, BVM&S, Dip.M., MRCVS

Senior Partner

Areas of Expertise: Pharmaceutical and biotechnology leadership, veterinary medicine, international business development, M&A

Leadership

Consulting

Operations

Business Development

Graham_Lumsden_headshot

Dr. Graham G. Lumsden, BVM&S, Dip.M., MRCVS

Senior Partner

Areas of Expertise: Pharmaceutical and biotechnology leadership, veterinary medicine, international business development, M&A

An accomplished pharmaceutical and biotechnology leader, Dr. Lumsden brings a mix of large and small company experience across U.S. and international markets. Recognized as a networker and team-builder, he has successfully built companies from scratch through IPOs, gaining a deep understanding of capital markets and delivering shareholder value.
Always focused on saving and/or improving patient lives, Dr. Lumsden has worked in many therapeutic areas, including infectious diseases, osteoporosis, women’s health, cardio- renal disease, oncology and inflammation/immunology.


Initially a practicing large animal veterinarian, he was recruited by Merck & Co., Inc. to assist in the U.K launch of IVOMEC (ivermectin). Dr. Lumsden relocated to the U.S. to lead the launch of GASTROGARD (omeprazole) for equines, the first new product launch at the newly formed Merial. Transitioning to human health, global responsibilities at Merck included CRIXIVAN (indinavir), FOSAMAX (alendronate) and NUVARING (etonogestrel/ethinyl estradiol). Leading cross-functional teams gave Dr. Lumsden experience across commercialization, clinical and non-clinical development, regulatory, CMC, finance, intellectual property, patent litigation and governmental affairs. He played a key role on the integration team during the acquisition by Merck of Schering Plough (SP), concluding in global responsibility for one of the legacy SP businesses.

His experience in the biotechnology world started with an opportunity to lead Motif Bio from a medicinal chemistry base, building a team from scratch, through the acquisition of a clinical stage antibacterial, iclaprim, completing two IPOs, raising over $125 million from the public markets, the successful completion of two Phase 3 clinical studies and submission of an NDA to FDA. Broad and deep experience of M&A was gained seeking commercialization partners and in-license candidates. Additional CEO and Board experience at private biotechnology companies has encompassed fund-raising, corporate restructuring, financial audits, cap table cleansing, and recruitment/management of CROs (clinical and non-clinical).


Dr. Lumsden is currently a member of the Board of Directors at Kibow Therapeutics, Inc., a profitable consumer and veterinary microbiome therapeutics business with a live biotherapeutic product in Phase 2 clinical development for patients with Stage 4 CKD.

Paul Martinetti, MD

Senior Partner

Areas of Expertise: opinion leader champion, clinical research precision, treatment efficacy scale development and validation, protocol training, professional training and development, digital innovation and quality assurance 

 

Consulting

Regulatory

Paul_Martinetti_Headshot

Paul Martinetti, MD

Senior Partner

Areas of Expertise: opinion leader champion, clinical research precision, treatment efficacy scale development and validation, protocol training, professional training and development, digital innovation and quality assurance 

 

Paul brings three areas of expertise to Bracken: digital software and hardware programming, general clinical practice, and professional training. His career journey is highlighted by successes in dermatology research and cancer survivorship. 

Paul led a collaboration between dermatology research experts and pharmaceutical treatment companies to invent, build, and implement an online photo-based acne severity consensus tool. The solution optimizes intra- and inter-rater reliability of treatment efficacy assessments. The research community embraced the solution, it replaced live-model training, and swept across the industry to over a dozen dermatology therapeutic areas during nearly two decades, reaching thousands of clinicians in over 50 studies in 20 countries. Ninety-eight percent of the studies using the solution were successful. 

When the industry leader wanted to pioneer a treatment for acne on the chest, shoulders and back, Paul led the team to invent, manufacture, and implement a clinical study t-shirt worn by patients during each assessment to ensure a consistent viewing area. His uncompromising dedication to research precision culminated in the approval of a treatment that has helped thousands of patients. 

In oncology survivorship, Paul partnered with Dr. Leslie R. Schover, a world-renowned expert in sexuality and fertility at the UT MD Anderson Cancer Center to develop resources for clinicians and patients that were funded by business grants from the US National Cancer Institute and the American Cancer Society. As cancer survivors live longer, they want to have families, and they face significant treatment-related infertility and sexual dysfunction. As a co-Investigator, Paul led the technology decision-making to ensure that Dr. Schover's multimedia content reached its audiences in clinical trial settings during 15 years of digital tech evolution, from basic HTML and disk media to a robust online CRM system with streaming HD videos. Doctors were taught how to engage with patients about these sensitive issues, and patients were better able to plan for surviving. This work yielded a comprehensive program for clinicians and patients, and two academic publications. 

Leveraging Bracken’s integrated approach to advancing the life sciences, and his own demonstrated expertise in digital health, Paul is eager to help his clients develop the next breakthrough innovation. 

Ashlyn Maurer

Account Manager

Position Title

MaurerAshlyn-final

Ashlyn Maurer

Account Manager

Ashlyn graduated from Temple University in 2016 and opted out of the “one-size-fits-all” approach. From event production and project management, to content creation and implementing digital marketing strategies, Ashlyn translates her eclectic professional endeavors through a glass-half-full mentality, making sure to always provide a positive experience along the way. Outside of work, Ashlyn is either gardening, listening to music or cuddling with her cats while reading a good, leather-bound book. 

Karen McCandless

Copywriter

Marketing Services

image-removebg-preview-2

Karen McCandless

Copywriter

Karen is a seasoned writer and digital marketing professional who specializes in B2B software and business communication. Karen has a passion for words and explaining technical concepts in easy-to-use language. When not typing frantically at her laptop, she enjoys trying new brunch spots, browsing second-hand bookshops, and going on last minute minibreaks.

Sandy McEwan, MD, BS, MSc, FRCPC, FSNMMI

Senior Partner

Areas of Expertise: Radioisotope therapy, molecular imaging, imaging biomarkers

Marketing Services

image-removebg-preview (2)

Sandy McEwan, MD, BS, MSc, FRCPC, FSNMMI

Senior Partner

Areas of Expertise: Radioisotope therapy, molecular imaging, imaging biomarkers

With over forty years of experience in oncology and nuclear medicine, Dr. McEwan is a world-renowned expert in his field. Most recently, he was Chief Medical Officer at Ariceum, a company developing novel medicines for systemic targeted radiotherapy (SRT), and immediately prior to that he was Vice President of Radiopharmaceuticals at Ipsen. As an academic physician, Dr. McEwan served as Chair of the Departments of Radiology and Oncology at the University of Alberta. Dr. McEwan has worked as a physician at Alberta Health Services for over thirty years, with additional postings that have included Clinical Director of the Cross Cancer Institute and Clinical Head of Diagnostic Imaging at the University of Alberta Hospital. Dr. McEwan has authored over 120 publications in oncology and radiopharmaceuticals and SRT.

Chelsea Miller, MA

Senior Consultant, Regulatory Affairs

Areas of Expertise: Maintaining IND/NDA/BLA submissions for the FDA, preparing & submitting & negotiating product submissions with the EPA and Health Canada, support and leadership with INDs

Consulting

Regulatory

Chelsea__5_-removebg-preview

Chelsea Miller, MA

Senior Consultant, Regulatory Affairs

Areas of Expertise: Maintaining IND/NDA/BLA submissions for the FDA, preparing & submitting & negotiating product submissions with the EPA and Health Canada, support and leadership with INDs

Chelsea is a Senior Regulatory consultant primarily focused on coordinating, compiling, submitting, and maintaining submissions, including INDs, NDAs, and BLAs for the FDA, and other global regulatory authorities. Her expertise extends to preparing, submitting, and negotiating product submissions with the EPA and Health Canada. She has led and supported the submission and maintenance of multiple INDs across a wide range of therapeutic areas.

Colin G. Miller, PhD, FIPEM, CSci

CEO

Areas of Expertise: Nuclear medicine & DXA & oncology & musculoskeletal imaging, strategic development for regulatory pathway for novel imaging companion diagnostics and FDA interactions, clinical trial support 

Leadership

Consulting

Operations

Business Development

m7-removebg-preview

Colin G. Miller, PhD, FIPEM, CSci

CEO

Areas of Expertise: Nuclear medicine & DXA & oncology & musculoskeletal imaging, strategic development for regulatory pathway for novel imaging companion diagnostics and FDA interactions, clinical trial support 

Colin is the CEO of Bracken and has previously held positions in senior management positions, including Vice President of strategy and Senior Vice President of Medical Affairs for 16 years at Bioclinica (now Clario). While the company was publicly traded on NASDAQ, Colin was an officer of the company for 5 years. During his tenure At Bioclinica Colin had responsibility for the science and medicine at the company supporting clients, and for 10 years he also managed all the corporate marketing. Colin is an accomplished scientistprimarily focused on the area of nuclear medicine, DXA, oncology, and musculoskeletal imaging, as well as the strategic development for the regulatory pathway for a novel imaging companion diagnostic and FDA interaction. He has spent his career working in the clinical trial arena and support the successful data submission for more than 20 products. 

Elliot Miller

Senior Partner

Leadership

Marketing Services

Business Development

Elliot_Headshot-removebg-preview

Elliot Miller

Senior Partner

Elliot is passionate about growing businesses through aggressive digital marketing tactics, and currently pursues this passion as Partner and Chief Marketer at Bracken Marketing. His previous roles have included small startups, major b2b tech players, and project managing across VC portfolios.

When asked about how and why his career brought him to joining the Bracken founding team he states: “The high-tech industry I once worked in became overcrowded. But now is the perfect time to apply the marketing strategies developed in this sector to digital health, pharma services, and eclinical teams. I find these teams have more opportunity than any other industry to use thoughtful marketing for differentiating from competitors, disrupting large yet slow competitors, capturing market share, and growing revenue.”

Kathryn Minzola

Director of Digital Marketing & Analytics

Marketing Services

image-removebg-preview (13)

Kathryn Minzola

Director of Digital Marketing & Analytics

Kathryn graduated from DeSales University with her bachelor’s in business administration and comes from a background in agency work; Kathryn has always been driven by helping clients achieve their marketing goals and is always up for a new challenge. She has a great personal demeanor and enjoys working closely with both clients and her teammates. In her free time, she enjoys spending quality time with her husband and 2 young children, taking on home DIY projects, spending time outdoors, shopping, and traveling!

Ben Mitchell

Senior Partner

Areas of Expertise: Information services, marketing specialization, analytics

Leadership

Marketing Services

Operations

Analytics

Ben_Mitchell

Ben Mitchell

Senior Partner

Areas of Expertise: Information services, marketing specialization, analytics

Ben is a systems and analytics expert with a proven track record of helping companies succeed.  His first independent start-up, The Brite Mind, built and deployed custom analytics to improve digital advertising and growth marketing outcomes. The Brite Mind was acquired by The Bracken Group in 2020, and Ben took on a leadership role within the firm, serving as Vice President of Operations and later transitioning to Vice President of Information Services and Analytics. As a consultant, he focuses on aiding clients take control of their data and optimize their tech stack to produce better measurable outcomes.

Victor Miranda, MBA, MD

Senior Partner

Areas of Expertise: Medical device development, medical and clinical affairs, osteoporosis

Consulting

victor2-removebg-preview

Victor Miranda, MBA, MD

Senior Partner

Areas of Expertise: Medical device development, medical and clinical affairs, osteoporosis

Victor recently served as Chief Medical Officer for 3M where he led efforts in Health Care Compliance and the integration of Medical/Clinical inputs into the product development process. He has also been a thought leader for the Frost & Sullivan Mind X-change and Q1 Productions. Victor also has experience in medical device development, medical and clinical affairs, health economics, reimbursement, post marketing studies, osteoporosis, in vitro diagnostics (IVD), cardiac electrophysiology, ophthalmology, diabetes, and head trauma.  

Kurt Mueller

Senior Partner

Areas of Expertise: Chief Digital Officer support in digital and omnichannel strategic planning, innovation in digital marketing and medical communications, and oversight of pull-through execution and analytics plan development

Consulting

imageedit_6_4328005517

Kurt Mueller

Senior Partner

Areas of Expertise: Chief Digital Officer support in digital and omnichannel strategic planning, innovation in digital marketing and medical communications, and oversight of pull-through execution and analytics plan development

Kurt Mueller has over two decades of expertise in creating digital and omnichannel solutions for the life sciences industry. He offers fractional Chief Digital Officer (CDO) and Chief Innovation Officer (CIO) services in areas such as digital marketing, medical communications, omnichannel integration, stakeholder segmentation, CX journey mapping, and metrics and analytics measurement frameworks that incorporate qualitative, quantitative, leading, and lagging indicators. He has collaborated with many of the leading pharmaceutical and biotech firms, as well as emerging companies in rare disease. Kurt is a respected thought leader who was named a PharmaVOICE Top 100 Marketer in the U.S., frequently speaks at industry events, and serves as a member of the editorial advisory board of PM360 magazine.

Abdel Otmani

Developer

Marketing Services

Abdel Otmani Headshot

Abdel Otmani

Developer

Abdel is a data fanatic, and is ready to tackle any data analysis challenge. He's most interested in how intelligence solutions use Big Data to help us understand human behavior. Abdel received his masters degree in Data Mining from University of Lyon and has over 12 years of experience in Business Intelligence and Data Science. He has done data consulting for large firms such as Volvo, and currently focuses on developing the next greatest Bracken Data features. He lives in Lyon, France and with his 3 children. Abdel enjoys beautiful cars, working out, reading post-apocalyptic books, and spending time with family.

William Reinus, MBA, MD

Senior Partner

Areas of Expertise: Clinical imaging: trials and endpoints, development of MRI techniques, optimization of imaging modalities

Consulting

Headshot_-_Website_2-removebg-preview

William Reinus, MBA, MD

Senior Partner

Areas of Expertise: Clinical imaging: trials and endpoints, development of MRI techniques, optimization of imaging modalities

Wil worked for over 35 years in clinical imaging as a Professor of Radiology, initially at the Mallinckrodt Institute in St Louis and then Temple University in Philadelphia before switching to industry and spending 5 years as a Medical Director of Icon Medical Imaging. He received an MBA from Washington University, Olin School of Business in 2000.  He has expertise and has published extensively in medical imaging, the development of magnetic resonance imaging (MRI) techniques and optimization of other imaging modalities to improve understanding of disease processes such as traumatic brain injury, stroke, and musculoskeletal disorders. As a practicing physician, Wil has been involved with clinical trials both from the clinical and the CRO sides with a specific focus on imaging endpoints. 

Ina Margaretha Rijnhout, MSc

Senior Partner

Areas of Expertise: Biotech leadership & business development, licensing, drug development, outsourcing strategies in Europe

Consulting

imageedit_1_6476380435

Ina Margaretha Rijnhout, MSc

Senior Partner

Areas of Expertise: Biotech leadership & business development, licensing, drug development, outsourcing strategies in Europe

Ina Margaretha is based in Amsterdam and has a 25 years of experience with the fields of clinical drug development, strategic partnerships, business development, and building innovative biotech businesses and CROs in Europe.

Ina Margaretha has been developing business plans for start-ups, organizing funding (including European grants), leading R&D programs, outsourcing development and commercial strategies to develop groundbreaking therapies in the field of immunology, allergy, inflammatory diseases (including post-COVID), musculoskeletal, orphan diseases and CNS, ultimately negotiating attractive licensing deals to accelerate time to market. She has also experience in gene and cell therapies and combined medical devices.

Over the course of her career, she has created strong relationships with life science investors, built strong scientific and operational teams, and developed long term partnerships with biopharma partners to bring innovative treatments to patients.

Ina Margaretha has a Master’s Degree in Biomedical Sciences from the Leiden University Medical Centre, The Netherlands.

Dianna Pathak

Advertising Specialist

Position Title

6c6f9e0f-af60-4779-84f2-478fe2c5eedc-removebg-preview

Dianna Pathak

Advertising Specialist

Dianna is an Advertising Specialist at The Bracken Group, where she brings over six years of experience in PPC, social media ads, analytics, and search engine optimization. With a keen analytical mindset, she continuously monitors campaign performance, leveraging data insights to optimize strategies and maximize return on investment. Dianna remains at the forefront of industry trends, ensuring Bracken's clients benefit from innovative solutions that elevate their brands in today's competitive landscape.

Marybeth Profrock

Senior Partner

Areas of Expertise: Executive leadership, marketing & sales growth, business development

Position Title

Marybeth_headshot

Marybeth Profrock

Senior Partner

Areas of Expertise: Executive leadership, marketing & sales growth, business development

Marybeth is a highly experienced results-oriented marketing executive with a strong track record of team building, strategic planning and tactical execution in fast-paced organizations. Marybeth serves as an account strategist and fractional Chief Marketing Officer to support digital innovation, B2B marketing, product marketing, partner marketing and content strategy for life sciences technology and digital health organizations. With her demonstrated history in Executive Leadership, Business Development, Sales Growth, and Marketing, Marybeth excels at quickly addressing root cause issues by applying analytical problem solving and optimize marketing aligning with business strategy to accelerate innovation and growth.

Elyse Rogers

Project Manager: Special Projects

Areas of Expertise: Project management, quality/regulatory/product development, manufacturing engineering

Position Title

RogersElyse-final

Elyse Rogers

Project Manager: Special Projects

Areas of Expertise: Project management, quality/regulatory/product development, manufacturing engineering

Elyse earned her Bachelor of Science degree in Psychology with an emphasis in Neuroscience from the University of Utah. Her collective experience in Project Management, Quality, Regulatory, Product Development, and Manufacturing Engineering practices, have been paramount in assisting clients through all stages of development. 

Andrew L. Salzman, MD

Senior Partner

Areas of Expertise: Biotech/pharmaceutical company leadership, drug development oversight, clinical use of cannabinoids

Consulting

Headshot_-_final-removebg-preview

Andrew L. Salzman, MD

Senior Partner

Areas of Expertise: Biotech/pharmaceutical company leadership, drug development oversight, clinical use of cannabinoids

Andrew (Andy) brings more than 40 years’ experience in the biotech/pharmaceutical industry having initiated and built several biotech companies including Inotek Pharmaceuticals Corporation, Radikal Therapeutics, Salzman Group, Chilmark Laboratories, and Orphan Technologies, where he oversaw the entire spectrum of drug development activities, including discovery chemistry, pharmacology, and preclinical activities, manufacturing, clinical Phase I-II, as well as the US and international regulatory strategies. Andy has over 170 peer-reviewed articles, 47 patents, and was the inventor and development lead for the clinical-stage PARP-1 inhibitor. More recently Andy’s focus and interest has been on the clinical use of cannabinoids.

Keegan Shepherd

Senior Copywriter

Position Title

Keegan headshot_edited (1)

Keegan Shepherd

Senior Copywriter

Living in Reno, Nevada, Keegan is building what he calls a “full circle” relationship with writing—making it a personal, professional, and academic pursuit. He spends his time outside of work making music, traveling, writing poetry, and creating new ice cream recipes. Keegan holds a Bachelor of Arts in English from the University of Nevada-Reno and has worked as a writing consultant, freelancer, and a copywriter/account coordinator. 

Rosemary Shull

Senior Partner

Areas of Expertise: Executive leadership, Marketing & Sales growth, business development

Position Title

IMG_8613

Rosemary Shull

Senior Partner

Areas of Expertise: Executive leadership, Marketing & Sales growth, business development

Rosemary has extensive sales and marketing experience in Medical Imaging, Software, Drug Development, Medical Devices, Oncology, Neuromuscular, Musculoskeletal and Metabolic diseases. With her demonstrated history in Executive Leadership, Business Development, Sales Growth, and Marketing in the medical device and pharmaceutical development industries, Rosemary excels at preparing and delivering presentations to investors as well as Board of Director members.  

Colby Stellhorn

Account Director

Marketing Services

Colby-Stellhorn

Colby Stellhorn

Account Director

Colby has been a marketing services executive for over twelve years, seven of those with an agency she founded that is still thriving today. Prior to starting her own agency, Colby worked as a Director of Sales and Marketing and was responsible for developing marketing campaigns that were responsible for B2B relationships that included HSN, QVC, and other larger retail chains. From large pharma to smaller boutique CROs, Colby enjoys utilizing her digital marketing expertise to strategize and implement winning campaigns that move the needle for her accounts. In her spare time, Colby enjoys spending time with her three girls and riding horses in the mountains of North Carolina.

Nick Spring, BSc (Hons), DipM, MCIM

Senior Partner

Areas of Expertise: Team building, strategic planning, and tactical execution in pharma, biotech, and medical device organizations

Consulting

m8-removebg-preview

Nick Spring, BSc (Hons), DipM, MCIM

Senior Partner

Areas of Expertise: Team building, strategic planning, and tactical execution in pharma, biotech, and medical device organizations

As a results-oriented executive, Nick has a strong track record of success in team building, strategic planning, and tactical execution in pharma, biotech, and medical device organizations. Previously Nick’s extensive experience includes senior executive positions at Merck, Merial and Reliefband providing him expertise with global drug, dietary supplements, nutraceuticals, biologicals, and med device development and commercialization experience. He is a serial entrepreneur taking companies from start up through financing stages to exit. Nick was the founder, Chairman, and CEO of Topaz Pharmaceuticals, the founder and managing partner of Humanitas Consulting, the co-founder of Reliefband Technologies, a med device company as well as co-founder of BioVeras – bringing blockchain to life sciences. In addition, Nick has served for 10 years as an Adjunct Professor at the University of the Sciences, Philadelphia, specializing in pharmaceutical, biotech and med device entrepreneurship, marketing, and commercialization as well as direct involvement with the PA Biotechnology Center, Doylestown, since 2005.

Tracey Tassinari

Graphic Designer

 

Marketing Services

image-removebg-preview (12)

Tracey Tassinari

Graphic Designer

 

Tracey Tassinari is a graphic designer based in beautiful Denver, Colorado. Originally from Connecticut, she has an educational background in both marketing and graphic design from The University of Connecticut, allowing her to bridge the gap between aesthetics and strategic results. She has been working in the digital and branding world for over 5 years now, working on small to large scale website designs and branding projects. A unique combination of thoughtfulness and playfulness is integral to her design process and she values positive and productive communication so that she can get close to the projects and people she works with.

Renju Thomas

Office Manager

Operations

Renju_Thomas_Headshot-removebg-preview

Renju Thomas

Office Manager

BS Degree in Computer Science with a minor in Mathematics from Chicago. Created and ran a business in the promotional products industry for several years. Love of numbers and detail-oriented nature segued into Office Management and Bookkeeping for several companies. Passion for volunteer work in the community and schools. Love being at the beach and the Jersey Shore. Enjoy reading books and belong to several book clubs. On a journey to learn new things and discover new talents such as painting and becoming a master Archer.

Nurcan Tosun, MBA, MA

Director, Strategic Partnerships & Business Development

Areas of Expertise: Business development, product management, sales 

Consulting

Business Development

nu-1-removebg-preview

Nurcan Tosun, MBA, MA

Director, Strategic Partnerships & Business Development

Areas of Expertise: Business development, product management, sales 

In her role as Director of Strategic Partnerships & Business Development at Bracken, Nurcan utilizes her extensive experience in the areas of product management, business development, sales, and data analysis. Nurcan holds a master’s degree in Business Administration from Carlson School of Management at the University of Minnesota with a special focus in the medical device industry. Before joining The Bracken Group, she managed the corporate accounts at International Osteoporosis Foundation in Switzerland. Nurcan started her career at Merck & Co. and has done product marketing and sales for osteoporosis, vaccines, and ophthalmology business units. Nurcan brings a vast knowledge of managing global teams with diverse set of people and loves to be part of the life sciences community.

Brad Wyman, MS, PhD

Senior Partner

Areas of Expertise: Clinical imaging, clinical trial design, developing and implementing imaging biomarkers in clinical studies

Consulting

_Brad-removebg-preview

Brad Wyman, MS, PhD

Senior Partner

Areas of Expertise: Clinical imaging, clinical trial design, developing and implementing imaging biomarkers in clinical studies

Brad is a recognized expert with more than 25 years of experience in clinical trial design. His extensive experience includes a 10-year tenure at Pfizer, where he played a pivotal role in developing and implementing imaging biomarkers in clinical studies across multiple therapeutic areas. Formerly, he held the position of Vice President of Imaging and Clinical Development at ImaginAb. In this role, he was responsible for the development and clinical testing of novel PET tracers. Currently, Brad collaborates with medical device and biotech companies, providing consultancy services to implement innovative biomarkers and design robust, data-driven studies. His expertise is invaluable in guiding through critical go/no-go development decisions, ensuring they are made based on solid, actionable insights.

Jen Yip

Senior Partner

Areas of Expertise: Chief Marketing Officer support in digital innovation, B2B marketing, content strategy for life science and digital health organizations

Consulting

Marketing Services

jenyip2-removebg-preview

Jen Yip

Senior Partner

Areas of Expertise: Chief Marketing Officer support in digital innovation, B2B marketing, content strategy for life science and digital health organizations

With a rich history of marketing, Jen provides fractional “Chief Marketing Officer” support in digital innovation, B2B marketing, product marketing, partner marketing, and content strategy for life sciences technology and digital health organizations. She has in-house experience at 3 top-ten pharmaceutical companies, and multiple life sciences healthcare technology vendors and marketing agencies supporting Fortune 500 and emerging brands.